Finance: Page 17

Shryne Group Names Gregory Fink as Chief Financial Officer

Fink, who previously worked at comScore and Fannie Mae, is responsible for streamlining operations to maximize Shryne Group's profitability.

Ascend Wellness Files Registration Statement; Has Option to Issue $100M of New Securities

The multistate cannabis operator’s filing on Form C-3 contains a base shelf prospectus with the U.S. Securities and Exchange.

California Cannabis Sales Hit 9-Quarter Low

The world’s largest legal market has also experienced declining tax revenues for five straight quarters.

Verano Announces 3Q 2022 Financial Results

The company’s third quarter 2022 revenue increased 2% versus the prior quarter and 10% year-over-year to $228 million.

Will Biden’s Order to Review Cannabis’s CSA Scheduling Impact Publicly Traded Cannabis Companies?

Cannabis experts and publicly traded operators weigh in on the announcement’s effects on stocks last month, as well what the future could hold if cannabis is either descheduled or rescheduled from its current Schedule I status in the Controlled Substances Act.

Canopy Growth Faces Possible Delisting From Nasdaq Upon US Entrance

Company officials stated there is no assurance that Nasdaq will harmonize its general policies with SEC’s accounting guidance.

SEC Charges Canadian Cannabis Company, Former Senior Executive With Accounting Fraud

The SEC officials found the company violated the antifraud, reporting, books and records, and internal controls provisions of the federal securities laws.

Flower One’s Canadian Parent Company Has Filed for Restructuring Proceedings

Understood as the Canadian version of the U.S. bankruptcy process, Flower One Holdings’ latest move suggests significant financial problems.

The Green Organic Dutchman Will Merge With BZAM Cannabis

The resulting business is expected to be the sixth largest cannabis cultivation company in Canada.

3 Former CannTrust Executives Face Fraud, Insider Trading Charges

The lawsuit involves the Ontario Securities Commission’s first court proceedings involving a publicly traded cannabis company.

Verano Repudiates $413M Deal to Acquire Goodness Growth Holdings

Goodness officials believe that Verano has “no legal” grounds for backing out of the transaction agreement and are committing “material breaches.”

Verano Bets $5 Million to Enter Virginia Medical Market

The multistate cannabis operator entered into an agreement to acquire MedMen’s PhamaCann Virginia LLC, which has a license tied up in litigation.

Previous Page

Page 17 of 193

Next Page